SEARCH

SEARCH BY CITATION

References

  • Abe K., Kogure K., Yamamoto H., Imazawa M. and Miyamoto K. (1987) Mechanism of arachidonic acid liberation during ischemia in gerbil cerebral cortex. J. Neurochem. 48, 503509.
  • Anton R. F., Wallis C. and Randall C. L. (1983) In vivo regional levels of PGE and thromboxane in mouse brain: effect of decapitation, focused microwave fixation, and indomethacin. Prostaglandins 26, 421429.
  • Basselin M., Chang L., Seemann R., Bell J. M. and Rapoport S. I. (2003) Chronic lithium administration potentiates brain arachidonic acid signaling at rest and during cholinergic activation in awake rats. J. Neurochem. 85, 15531562.
  • Basselin M., Chang L., Bell J. M. and Rapoport S. I. (2005) Chronic lithium chloride administration to unanesthetized rats attenuates brain dopamine D2-like receptor-initiated signaling via arachidonic acid. Neuropsychopharmacology 30, 10641075.
  • Basselin M., Chang L., Bell J. M. and Rapoport S. I. (2006a) Chronic lithium chloride administration attenuates brain NMDA receptor-initiated signaling via arachidonic acid in unanesthetized rats. Neuropsychopharmacology 31, 16591674.
  • Basselin M., Villacreses N. E., Langenbach R., Ma K., Bell J. M. and Rapoport S. I. (2006b) Resting and arecoline-stimulated brain metabolism and signaling involving arachidonic acid are altered in the cyclooxygenase-2 knockout mouse. J. Neurochem. 96, 669679.
  • Bazan N. G., Rodriguez de Turco E. B. and Allan G. (1995) Mediators of injury in neurotrauma: intracellular signal transduction and gene expression. J. Neurotrauma. 12, 791814.
  • Bazinet R. P., Lee H. J., Felder C. C., Porter A. C., Rapoport S. I. and Rosenberger T. A. (2005) Rapid high-energy microwave fixation is required to determine the anandamide (N-arachidonoylethanolamine) concentration of rat brain. Neurochem. Res. 30, 597601.
  • Bazinet R. P., Weis M. T., Rapoport S. I. and Rosenberger T. A. (2006a) Valproic acid selectively inhibits conversion of arachidonic acid to arachidonoyl-CoA by brain microsomal long-chain fatty acyl-CoA synthetases: relevance to bipolar disorder. Psychopharmacology (Berl.) 184, 122129.
  • Bazinet R. P., Rao J. S., Chang L., Rapoport S. I. and Lee H. J. (2006b) Chronic carbamazepine decreases the incorporation rate and turnover of arachidonic acid but not docosahexaenoic acid in brain phospholipids of the unanesthetized rat: relevance to bipolar disorder. Biol. Psychiatry 59, 401407.
  • Bezzi P., Carmignoto G., Pasti L., Vesce S., Rossi D., Rizzini B. L., Pozzan T. and Volterra A. (1998) Prostaglandins stimulate calcium-dependent glutamate release in astrocytes. Nature 391, 281285.
  • Bezzi P., Domercq M., Brambilla L. et al. (2001) CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity. Nat. Neurosci. 4, 702710.
  • Bosetti F., Seemann R., Bell J. M., Zahorchak R., Friedman E., Rapoport S. I. and Manickam P. (2002a) Analysis of gene expression with cDNA microarrays in rat brain after 7 and 42 days of oral lithium administration. Brain Res. Bull. 57, 205209.
  • Bosetti F., Rintala J., Seemann R., Rosenberger T. A., Contreras M. A., Rapoport S. I. and Chang M. C. (2002b) Chronic lithium downregulates cyclooxygenase-2 activity and prostaglandin E2 concentration in rat brain. Mol. Psychiatry 7, 845850.
  • Bosetti F., Weerasinghe G. R., Rosenberger T. A. and Rapoport S. I. (2003) Valproic acid down-regulates the conversion of arachidonic acid to eicosanoids via cyclooxygenase-1 and -2 in rat brain. J. Neurochem. 85, 690696.
  • Bosetti F., Langenbach R. and Weerasinghe G. R. (2004) Prostaglandin E2 and microsomal prostaglandin E synthase-2 expression are decreased in the cyclooxygenase-2-deficient mouse brain despite compensatory induction of cyclooxygenase-1 and Ca2+-dependent phospholipase A2. J. Neurochem. 91, 13891397.
  • Bosisio E., Galli C., Galli G., Nicosia S., Spagnuolo C. and Tosi L. (1976) Correlation between release of free arachidonic acid and prostaglandin formation in brain cortex and cerebellum. Prostaglandins 11, 773781.
  • Bradford M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248254.
  • Brodal A. (1981) Neurological Anatomy in Relation to Clinical Medicine, 3rd edn. Oxford University Press, Oxford.
  • Chang M. C. and Jones C. R. (1998) Chronic lithium treatment decreases brain phospholipase A2 activity. Neurochem. Res. 23, 887892.
  • Chang M. C., Grange E., Rabin O., Bell J. M., Allen D. D. and Rapoport S. I. (1996) Lithium decreases turnover of arachidonate in several brain phospholipids. Neurosci. Lett. 220, 171174.
  • Chang M. C., Contreras M. A., Rosenberger T. A., Rintala J. J., Bell J. M. and Rapoport S. I. (2001a) Chronic valproate treatment decreases the in vivo turnover of arachidonic acid in brain phospholipids: a possible common effect of mood stabilizers. J. Neurochem. 77, 796803.
  • Chang R. C., Chen W., Hudson P., Wilson B., Han D. S. and Hong J. S. (2001b) Neurons reduce glial responses to lipopolysaccharide (LPS) and prevent injury of microglial cells from over-activation by LPS. J. Neurochem. 76, 10421049.
  • Choi S. H., Langenbach R. and Bosetti F. (2006) Cyclooxygenase-1 and -2 enzymes differentially regulate the brain upstream NF-kappaB pathway and downstream enzymes involved in prostaglandin biosynthesis. J. Neurochem. 98, 801811.
  • Chuang D. M., Chen R. W., Chalecka-Franaszek E., Ren M., Hashimoto R., Senatorov V., Kanai H., Hough C., Hiroi T. and Leeds P. (2002) Neuroprotective effects of lithium in cultured cells and animal models of diseases. Bipolar Disord. 4, 129136.
  • Corsini E., Dufour A., Ciusani E., Gelati M., Frigerio S., Gritti A., Cajola L., Mancardi G. L., Massa G. and Salmaggi A. (1996) Human brain endothelial cells and astrocytes produce IL-1 beta but not IL-10. Scand. J. Immunol. 44, 506511.
  • DeMar J. C. Jr, Ma K., Bell J. M. and Rapoport S. I. (2004) Half-lives of docosahexaenoic acid in rat brain phospholipids are prolonged by 15 weeks of nutritional deprivation of n-3 polyunsaturated fatty acids. J. Neurochem. 91, 11251137.
  • Descamps L., Cecchelli R. and Torpier G. (1997) Effects of tumor necrosis factor on receptor-mediated endocytosis and barrier functions of bovine brain capillary endothelial cell monolayers. J. Neuroimmunol. 74, 173184.
  • Deutsch J., Rapoport S. I. and Purdon A. D. (1997) Relation between free fatty acid and acyl-CoA concentrations in rat brain following decapitation. Neurochem. Res. 22, 759765.
  • Dinarello C. A. (2002) The IL-1 family and inflammatory diseases. Clin. Exp. Rheumatol. 20, S1S13.
  • Dirnagl U., Iadecola C. and Moskowitz M. A. (1999) Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 22, 391397.
  • Dorman R. V. (1988) Effects of cerebral ischemia and reperfusion on prostanoid accumulation in unanesthetized and pentobarbital-treated gerbils. J. Cereb. Blood Flow Metab. 8, 609612.
  • Dumuis A., Sebben M., Haynes L., Pin J. P. and Bockaert J. (1988) NMDA receptors activate the arachidonic acid cascade system in striatal neurons. Nature 336, 6870.
  • Esposito G., Giovacchini G., Der M. et al. (2007) Imaging signal transduction via arachidonic acid in the human brain during visual stimulation, by means of positron emission tomography. Neuroimage. 34, 13421351.
  • Fafeur V., Jiang Z. P. and Bohlen P. (1991) Signal transduction by bFGF, but not TGF beta 1, involves arachidonic acid metabolism in endothelial cells. J. Cell. Physiol. 149, 277283.
  • Folch J., Lees M. and Sloane Stanley G. H. (1957) A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226, 497509.
  • Ghelardoni S., Tomita Y. A., Bell J. M., Rapoport S. I. and Bosetti F. (2004) Chronic carbamazepine selectively downregulates cytosolic phospholipase A2 expression and cyclooxygenase activity in rat brain. Biol. Psychiatry 56, 248254.
  • Giovacchini G., Chang M. C., Channing M. A. et al. (2002) Brain incorporation of [11C]arachidonic acid in young healthy humans measured with positron emission tomography. J. Cereb. Blood Flow Metab. 22, 14531462.
  • Giovacchini G., Lerner A., Toczek M. T., Fraser C., Ma K., DeMar J. C., Herscovitch P., Eckelman W. C., Rapoport S. I. and Carson R. E. (2004) Brain incorporation of [11C]arachidonic acid, blood volume, and blood flow in healthy aging: a study with partial-volume correction. J. Nucl. Med. 45, 14711479.
  • Glezer I., Munhoz C. D., Kawamoto E. M., Marcourakis T., Avellar M. C. and Scavone C. (2003) MK-801 and 7-Ni attenuate the activation of brain NF-kappa B induced by LPS. Neuropharmacology 45, 11201129.
  • Goralski K. B., Abdulla D., Sinal C. J., Arsenault A. and Renton K. W. (2005) Toll-like receptor-4 regulation of hepatic Cyp3a11 metabolism in a mouse model of LPS-induced CNS inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 289, G434G443.
  • Hardardottir I., Grunfeld C. and Feingold K. R. (1994) Effects of endotoxin and cytokines on lipid metabolism. Curr. Opin. Lipidol. 5, 207215.
  • Hauss-Wegrzyniak B., Lukovic L., Bigaud M. and Stoeckel M. E. (1998a) Brain inflammatory response induced by intracerebroventricular infusion of lipopolysaccharide: an immunohistochemical study. Brain Res. 794, 211224.
  • Hauss-Wegrzyniak B., Dobrzanski P., Stoehr J. D. and Wenk G. L. (1998b) Chronic neuroinflammation in rats reproduces components of the neurobiology of Alzheimer’s disease. Brain Res. 780, 294303.
  • Hauss-Wegrzyniak B., Willard L. B., Del Soldato P., Pepeu G. and Wenk G. L. (1999) Peripheral administration of novel anti-inflammatories can attenuate the effects of chronic inflammation within the CNS. Brain Res. 815, 3643.
  • Hunot S. and Hirsch E. C. (2003) Neuroinflammatory processes in Parkinson’s disease. Ann. Neurol. 53(Suppl. 3), S49S58.
  • Iadecola C., Niwa K., Nogawa S., Zhao X., Nagayama M., Araki E., Morham S. and Ross M. E. (2001) Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice. Proc. Natl Acad. Sci. USA 98, 12941299.
  • Ikeda-Matsuo Y., Ikegaya Y., Matsuki N., Uematsu S., Akira S. and SasakiY. (2005) Microglia-specific expression of microsomal prostaglandin E2 synthase-1 contributes to lipopolysaccharide-induced prostaglandin E2 production. J. Neurochem. 94, 15461558.
  • Jung H. and Reme C. (1994) Light-evoked arachidonic acid release in the retina: illuminance/duration dependence and the effects of quinacrine, mellitin and lithium. Light-evoked arachidonic acid release. Graefes Arch. Clin. Exp. Ophthalmol. 232, 167175.
  • Kim W. G., Mohney R. P., Wilson B., Jeohn G. H., Liu B. and Hong J. S. (2000) Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia. J. Neurosci. 20, 63096316.
  • Kramer R. M. and Sharp J. D. (1997) Structure, function and regulation of Ca2+-sensitive cytosolic phospholipase A2 (cPLA2). FEBS Lett. 410, 4953.
  • Lampe H. and Bigalke H. (1990) Carbamazepine blocks NMDA-activated currents in cultured spinal cord neurons. Neuroreport 1, 2628.
  • Lee J. M., Grabb M. C., Zipfel G. J. and Choi D. W. (2000) Brain tissue responses to ischemia. J. Clin. Invest. 106, 723731.
  • Lee H., Villacreses N. E., Rapoport S. I. and Rosenberger T. A. (2004) In vivo imaging detects a transient increase in brain arachidonic acid metabolism: a potential marker of neuroinflammation. J. Neurochem. 91, 936945.
  • Lehnardt S., Lachance C., Patrizi S., Lefebvre S., Follett P. L., Jensen F. E., Rosenberg P. A., Volpe J. J. and Vartanian T. (2002) The toll-like receptor TLR4 is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CNS. J. Neurosci. 22, 24782486.
  • Lehnardt S., Massillon L., Follett P., Jensen F. E., Ratan R., Rosenberg P. A., Volpe J. J. and Vartanian T. (2003) Activation of innate immunity in the CNS triggers neurodegeneration through a toll-like receptor 4-dependent pathway. Proc. Natl Acad. Sci. USA 100, 85148519.
  • Li S., Ballou L. R., Morham S. G. and Blatteis C. M. (2001) Cyclooxygenase-2 mediates the febrile response of mice to interleukin-1beta. Brain Res. 910, 163173.
  • Luschen S., Adam D., Ussat S., Kreder D., Schneider-Brachert W., Kronke M. and Adam-Klages S. (2000) Activation of ERK1/2 and cPLA(2) by the p55 TNF receptor occurs independently of FAN. Biochem. Biophys. Res. Commun. 274, 506512.
  • Ma J. and Zhang G. Y. (2003) Lithium reduced N-methyl-D-aspartate receptor subunit 2A tyrosine phosphorylation and its interactions with Src and Fyn mediated by PSD-95 in rat hippocampus following cerebral ischemia. Neurosci. Lett. 348, 185189.
  • Ma J., Zhang G. Y., Liu Y., Yan J. Z. and Hao Z. B. (2004) Lithium suppressed Tyr-402 phosphorylation of proline-rich tyrosine kinase (Pyk2) and interactions of Pyk2 and PSD-95 with NR2A in rat hippocampus following cerebral ischemia. Neurosci. Res. 49, 357362.
  • Makrides M., Neumann M. A., Byard R. W., Simmer K. and Gibson R. A. (1994) Fatty acid composition of brain, retina, and erythrocytes in breast- and formula-fed infants. Am. J. Clin. Nutr. 60, 189194.
  • Martin E. D. and Pozo M. A. (2004) Valproate reduced excitatory postsynaptic currents in hippocampal CA1 pyramidal neurons. Neuropharmacology 46, 555561.
  • McGeer P. L. and McGeer E. G. (2004) Inflammation and neurodegeneration in Parkinson’s disease. Parkinsonism Relat. Disord. 10(Suppl. 1), S3S7.
  • Minghetti L. (2004) Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases. J. Neuropathol. Exp. Neurol. 63, 901910.
  • Minghetti L. (2005) Role of inflammation in neurodegenerative diseases. Curr. Opin. Neurol. 18, 315321.
  • Montine K. S., Quinn J. F., Zhang J., Fessel J. P., Roberts L. J. II, Morrow J. D. and Montine T. J. (2004) Isoprostanes and related products of lipid peroxidation in neurodegenerative diseases. Chem. Phys. Lipids 128, 117124.
  • Morri H., Ozaki M. and Watanabe Y. (1994) 5′-flanking region surrounding a human cytosolic phospholipase A2 gene. Biochem. Biophys. Res. Commun. 205, 611.
  • Nadeau S. and Rivest S. (1999) Effects of circulating tumor necrosis factor on the neuronal activity and expression of the genes encoding the tumor necrosis factor receptors (p55 and p75) in the rat brain: a view from the blood-brain barrier. Neuroscience 93, 14491464.
  • Nakamura Y., Ohmaki M., Murakami K. and Yoneda Y. (2003) Involvement of protein kinase C in glutamate release from cultured microglia. Brain Res. 962, 122128.
  • Nonaka S., Hough C. J. and Chuang D. M. (1998) Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N-methyl-D-aspartate receptor-mediated calcium influx. Proc. Natl Acad. Sci. USA 95, 26422647.
  • Patrizio M., Costa T. and Levi G. (1995) Interferon-gamma and lipopolysaccharide reduce cAMP responses in cultured glial cells: reversal by a type IV phosphodiesterase inhibitor. Glia 14, 94100.
  • Paxinos G. and Watson C. (1987) The Rat Brain in Stereotaxic Coordinates, 3rd edn. Academic Press, New York.
  • Pepicelli O., Fedele E., Bonanno G., Raiteri M., Ajmone-Cat M. A., Greco A., Levi G. and Minghetti L. (2002) In vivo activation of N-methyl-D-aspartate receptors in the rat hippocampus increases prostaglandin E2 extracellular levels and triggers lipid peroxidation through cyclooxygenase-mediated mechanisms. J. Neurochem. 81, 10281034.
  • Persson M., Brantefjord M., Hansson E. and Ronnback L. (2005) Lipopolysaccharide increases microglial GLT-1 expression and glutamate uptake capacity in vitro by a mechanism dependent on TNF-alpha. Glia 51, 111120.
  • Pettigrew L. C., Grotta J. C., Rhoades H. M. and Wu K. K. (1989) Effect of thromboxane synthase inhibition on eicosanoid levels and blood flow in ischemic rat brain. Stroke 20, 627632.
  • Pfeilschifter J., Reme C. and Dietrich C. (1988) Light-induced phosphoinositide degradation and light-induced structural alterations in the rat retina are enhanced after chronic lithium treatment. Biochem. Biophys. Res. Commun. 156, 11111119.
  • Poddubiuk Z. M., Blumberg J. B. and Kopin I. J. (1982) Brain prostaglandin content in rats sacrificed by decapitation vs focused microwave irradiation. Experientia 38, 987988.
  • Preston J. E. (2001) Ageing choroid plexus-cerebrospinal fluid system. Microsc. Res. Tech. 52, 3137.
  • Qin L., Li G., Qian X., Liu Y., Wu X., Liu B., Hong J. S. and Block M. L. (2005) Interactive role of the toll-like receptor 4 and reactive oxygen species in LPS-induced microglia activation. Glia 52, 7884.
  • Rabin O., Chang M. C., Grange E., Bell J., Rapoport S. I., Deutsch J. and Purdon A. D. (1998) Selective acceleration of arachidonic acid reincorporation into brain membrane phospholipid following transient ischemia in awake gerbil. J. Neurochem. 70, 325334.
  • Radin N. S. (1981) Extraction of tissue lipids with a solvent of low toxicity. Meth. Enzymol. 72, 57.
  • Rao J. S., Rapoport S. I. and Bosetti F. (2005) Decrease in the AP-2 DNA-binding activity and in the protein expression of AP-2 alpha and AP-2 beta in frontal cortex of rats treated with lithium for 6 weeks. Neuropsychopharmacology 30, 20062013.
  • Rapoport S. I. (2001) In vivo fatty acid incorporation into brain phospholipids in relation to plasma availability, signal transduction and membrane remodeling. J. Mol. Neurosci. 16, 243261.
  • Rapoport S. I., Chang M. C. and Spector A. A. (2001) Delivery and turnover of plasma-derived essential PUFAs in mammalian brain. J. Lipid Res. 42, 678685.
  • Richardson R. L., Kim E. M., Gardiner T. and O’Hare E. (2005) Chronic intracerebroventricular infusion of lipopolysaccharide: effects of ibuprofen treatment and behavioural and histopathological correlates. Behav. Pharmacol. 16, 531541.
  • Rintala J., Seemann R., Chandrasekaran K., Rosenberger T. A., Chang L., Contreras M. A., Rapoport S. I. and Chang M. C. (1999) 85 kDa cytosolic phospholipase A2 is a target for chronic lithium in rat brain. Neuroreport 10, 38873890.
  • Robinson P. J., Noronha J., DeGeorge J. J., Freed L. M., Nariai T. and Rapoport S. I. (1992) A quantitative method for measuring regional in vivo fatty-acid incorporation into and turnover within brain phospholipids: review and critical analysis. Brain Res. Brain Res. Rev. 17, 187214.
  • Rosenberger T. A., Villacreses N. E., Contreras M. A., Bonventre J. V. and Rapoport S. I. (2003) Brain lipid metabolism in the cPLA2 knockout mouse. J. Lipid Res. 44, 109117.
  • Rosenberger T. A., Villacreses N. E., Hovda J. T., Bosetti F., Weerasinghe G., Wine R. N., Harry G. J. and Rapoport S. I. (2004) Rat brain arachidonic acid metabolism is increased by a 6-day intracerebral ventricular infusion of bacterial lipopolysaccharide. J. Neurochem. 88, 11681178.
  • Rosi S., Vazdarjanova A., Ramirez-Amaya V., Worley P. F., Barnes C. A. and Wenk G. L. (2006) Memantine protects against LPS-induced neuroinflammation, restores behaviorally-induced gene expression and spatial learning in the rat. Neuroscience 142, 13031315.
  • Savchenko V. L., McKanna J. A., Nikonenko I. R. and Skibo G. G. (2000) Microglia and astrocytes in the adult rat brain: comparative immunocytochemical analysis demonstrates the efficacy of lipocortin 1 immunoreactivity. Neuroscience 96, 195203.
  • Shimizu T. and Wolfe L. S. (1990) Arachidonic acid cascade and signal transduction. J. Neurochem. 55, 115.
  • Skipski V. P., Good J. J., Barclay M. and Reggio R. B. (1968) Quantitative analysis of simple lipid classes by thin-layer chromatography. Biochim. Biophys. Acta 152, 1019.
  • Stephenson D. T., Lemere C. A., Selkoe D. J. and Clemens J. A. (1996) Cytosolic phospholipase A2 (cPLA2) immunoreactivity is elevated in Alzheimer’s disease brain. Neurobiol. Dis. 3, 5163.
  • Tabachnick B. G. and Fidell L. S. (2001) Computer-assisted Research Design and Analysis, pp. 184188. Allyn and Bacon Edition, Boston.
  • Uchiumi D., Kobayashi M., Tachikawa T. and Hasegawa K. (2004) Subcutaneous and continuous administration of lipopolysaccharide increases serum levels of triglyceride and monocyte chemoattractant protein-1 in rats. J. Periodontal Res. 39, 120128.
  • Wang Y. S. and White T. D. (1999) The bacterial endotoxin lipopolysaccharide causes rapid inappropriate excitation in rat cortex. J. Neurochem. 72, 652660.
  • Weerasinghe G. R., Seemann R., Rapoport S. I. and Bosetti F. (2003) Lithium chloride, administered chronically to rats, does not affect the fractional phosphorylation of brain cytosolic phospholipase A2, while reducing its net protein level. Brain Res. Bull. 59, 303306.
  • Weerasinghe G. R., Rapoport S. I. and Bosetti F. (2004) The effect of chronic lithium on arachidonic acid release and metabolism in rat brain does not involve secretory phospholipase A2 or lipoxygenase/cytochrome P450 pathways. Brain Res. Bull. 63, 485489.
  • Weichel O., Hilgert M., Chatterjee S. S., Lehr M. and Klein J. (1999) Bilobalide, a constituent of Ginkgo biloba, inhibits NMDA-induced phospholipase A2 activation and phospholipid breakdown in rat hippocampus. Naunyn Schmiedebergs Arch. Pharmacol. 360, 609615.
  • Wenk G. L., Rosi S., McGann K. and Hauss-Wegrzyniak B. (2002) A nitric oxide-donating flurbiprofen derivative reduces neuroinflammation without interacting with galantamine in the rat. Eur. J. Pharmacol. 453, 319324.
  • Weydt P. and Moller T. (2005) Neuroinflammation in the pathogenesis of amyotrophic lateral sclerosis. Neuroreport 16, 527531.
  • Willard L. B., Hauss-Wegrzyniak B., Danysz W. and Wenk G. L. (2000) The cytotoxicity of chronic neuroinflammation upon basal forebrain cholinergic neurons of rats can be attenuated by glutamatergic antagonism or cyclooxygenase-2 inhibition. Exp. Brain Res. 134, 5865.